Poland· PL-100123395
Ceel
A ascorbic acid (vitamin c), combinations product containing acidum ascorbicum + tocopheroli acetas, registered in Poland by Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI". The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Acidum ascorbicum + tocopheroli acetas is registered in 4 of 19 countries.
Countries holding a registration under ATC A11GB (ascorbic acid (vitamin c), combinations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Acidum ascorbicum + tocopheroli acetas · ATC A11GB
4 / 19 countries
- Finlandprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum ascorbicum + Tocopheroli acetas
- Manufacturer
- Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
- Country
- Poland (PL)
- ATC code
- A11GB
- ATC class
- Ascorbic acid (vitamin C), combinations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991062415
- gtin05909991062422
- gtin05909991062439
- gtin05909991062446
- gtin05909990892464
- gtin05909990892471
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A11GB
Ascorbic acid (vitamin c), combinations, as other registers publish it.
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, KautablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, KautablettenBayer (Schweiz) AG
- IrelandRedoxon Double Action 1000 mg/10 mg Effervescent TabletsBayer Limited
- FinlandRedoxon PlusBayer Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9551798-e03d-4a27-80f1-eb0d237ee19b GET /v1/drugs/c9551798-e03d-4a27-80f1-eb0d237ee19b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 100 mg",
"packaging": "05909991062415 ¦ OTC ¦ 23240\n20 tabl.\n05909991062422 ¦ OTC ¦ 23241\n30 tabl.\n05909991062439 ¦ OTC ¦ Skasowane ¦ 23242\n50 tabl.\n05909991062446 ¦ OTC ¦ 23243\n60 tabl. w blistrze\n05909990892464 ¦ OTC ¦ 68497\n50 tabl.\n05909990892471 ¦ OTC ¦ 68498\n60 tabl. w pojemniku",
"substance": "Acidum ascorbicum 50 mg + Tocopheroli acetas 100 mg",
"common_name": "Acidum ascorbicum + Tocopheroli acetas",
"pl_product_id": "100123395",
"pozwolenie_nr": "10624",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about acidum ascorbicum + tocopheroli acetas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.